# H-36731: Finasteride in Management of Elevated Red Blood Cells

> **NCT02548117** · PHASE3 · WITHDRAWN · sponsor: **Baylor College of Medicine**

## Conditions studied

- ERYTHROCYTOSIS

## Interventions

- **DRUG:** Finasteride

## Key facts

- **NCT ID:** NCT02548117
- **Lead sponsor:** Baylor College of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-02
- **Primary completion:** 2016-02
- **Final completion:** 2016-02
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Funding was not available.
- **Last updated:** 2019-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02548117

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02548117, "H-36731: Finasteride in Management of Elevated Red Blood Cells". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02548117. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*